118 related articles for article (PubMed ID: 22708070)
1. Cytotoxic and Immunochemical Properties of Viscumin Encapsulated
in Polylactide Microparticles.
Kolotova ES; Egorova SG; Ramonova AA; Bogorodski SE; Popov VK; Agapov II; Kirpichnikov MP
Acta Naturae; 2012 Jan; 4(1):101-6. PubMed ID: 22708070
[TBL] [Abstract][Full Text] [Related]
2. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
Thote AJ; Gupta RB
Nanomedicine; 2005 Mar; 1(1):85-90. PubMed ID: 17292062
[TBL] [Abstract][Full Text] [Related]
3. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
[TBL] [Abstract][Full Text] [Related]
4. Protein encapsulation via porous CaCO3 microparticles templating.
Volodkin DV; Larionova NI; Sukhorukov GB
Biomacromolecules; 2004; 5(5):1962-72. PubMed ID: 15360312
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Lu L; Yaszemski MJ; Mikos AG
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment.
Holland TA; Tessmar JK; Tabata Y; Mikos AG
J Control Release; 2004 Jan; 94(1):101-14. PubMed ID: 14684275
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
Lu L; Stamatas GN; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system.
Seemann S; Hauff P; Schultze-Mosgau M; Lehmann C; Reszka R
Pharm Res; 2002 Mar; 19(3):250-7. PubMed ID: 11934230
[TBL] [Abstract][Full Text] [Related]
10. Action of viscumin, a toxic lectin from mistletoe, on cells in culture.
Stirpe F; Sandvig K; Olsnes S; Pihl A
J Biol Chem; 1982 Nov; 257(22):13271-7. PubMed ID: 7142145
[TBL] [Abstract][Full Text] [Related]
11. A new antigenic epitope appears in the catalytic subunit of viscumin during intracellular transport.
Tonevitsky AG; Agapov II; Moisenovich MM; Maluchenko NV; Pashkov VS; Balashova TA; Kirpichnikov MP
Biochemistry (Mosc); 2003 Mar; 68(3):275-85. PubMed ID: 12733969
[TBL] [Abstract][Full Text] [Related]
12. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers.
Yan C; Rill WL; Malli R; Hewetson J; Tammariello R; Kende M
Vaccine; 1995 May; 13(7):645-51. PubMed ID: 7668034
[TBL] [Abstract][Full Text] [Related]
13. Preparation of Viscumin-Ferromagnetic Particles Conjugate and Study of Its Internalization by Human Glioblastoma A172 Cells.
Khutornenko AA; Gerasimov VM; Sakharov DA
Bull Exp Biol Med; 2016 Apr; 160(6):823-6. PubMed ID: 27165082
[TBL] [Abstract][Full Text] [Related]
14. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents.
Balmayor ER; Tuzlakoglu K; Marques AP; Azevedo HS; Reis RL
J Mater Sci Mater Med; 2008 Apr; 19(4):1617-23. PubMed ID: 18214645
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin encapsulation in biodegradable poly(epsilon-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility.
Le Ray AM; Chiffoleau S; Iooss P; Grimandi G; Gouyette A; Daculsi G; Merle C
Biomaterials; 2003 Feb; 24(3):443-9. PubMed ID: 12423599
[TBL] [Abstract][Full Text] [Related]
16. Polymer encapsulation of amoxicillin microparticles by SAS process.
Montes A; Baldauf E; Gordillo MD; Pereyra CM; Martínez de la Ossa EJ
J Microencapsul; 2014; 31(1):16-22. PubMed ID: 23701219
[TBL] [Abstract][Full Text] [Related]
17. Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine.
Nayak B; Ray AR; Panda AK; Ray P
J Biomater Appl; 2011 Jan; 25(5):469-96. PubMed ID: 20207774
[TBL] [Abstract][Full Text] [Related]
18. Cross-linked chitosan microparticles preparation by modified three fluid nozzle spray drying approach.
Gover Antoniraj M; Maria Leena M; Moses JA; Anandharamakrishnan C
Int J Biol Macromol; 2020 Mar; 147():1268-1277. PubMed ID: 31770556
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles.
Dunne M; Bibby DC; Jones JC; Cudmore S
J Control Release; 2003 Sep; 92(1-2):209-19. PubMed ID: 14499198
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
Wichert B; Rohdewald P
J Microencapsul; 1993; 10(2):195-207. PubMed ID: 8392542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
